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Objectives: Our research examined the barriers to the uptake of intrauterine contraception 
(IUC) by women in a general practice (GP) setting in the UK. This study reports predictors of 
non-use of IUC in this context.
Design: We used a mixed method Qual/Quant approach in which the initial qualitative research 
provides a framework for subsequent larger quantitative surveys. Utilizing findings derived 
from 30 qualitative interviews, a quantitative survey was developed and distributed to a prag-
matic sample of 1,195 women, aged 18–49 years, who were recruited through 32 participating 
GP practices in an area of England, UK. Outcome measures were percentage of attributes or 
responses in the sample and use or non-use of IUC. Results were analyzed using descriptive 
statistical analysis and binary logistic regression, using use/non-use as a binary response variable.
Results: Attitudinal variables, which were the strongest predictors of non-use of IUC, were an 
adverse opinion on long-acting aspect of IUC (odds ratio [OR]=8.34), disliking the thought of 
IUC inside the body (OR=3.138), concerns about IUC causing difficulties becoming pregnant 
in the future (OR=2.587), concerns about womb damage (OR=2.224), having heard adverse 
opinions about levonorgestrel-releasing intrauterine system (Mirena®) (OR=2.551), having an 
adverse opinion of having light, irregular periods (OR=2.382) and, having an adverse opinion 
of having no periods (OR=2.018).
Conclusion: Concerns about the long-acting nature of IUC and persisting concerns about the 
safety of IUC may act as barriers to its use. Information for women, tailored to specifically 
address these concerns, is needed.
Implications: Clinicians should provide more reassurance and information to potential users 
of IUC to increase their confidence about the possibility of removing IUC early or on request. 
They should also specifically seek to alleviate concerns about internal damage, damage to the 
womb, or damage to future fertility from using the methods.
Keywords: intrauterine device, intrauterine contraception, intrauterine system, general 
 practice, UK
Introduction
Intrauterine contraception (IUC) is safe, highly effective and, as with all methods of 
contraception, available free to women in the UK. Long-acting reversible contraceptive 
(LARC) methods are recommended by the UK National Institute of Clinical Excel-
lence (NICE) because of their cost-effectiveness and potential to reduce the numbers 
of unplanned and unwanted pregnancies.1 Despite its effectiveness, of those women 
attending UK community contraceptive clinics in 2014–2015, only 9% were using 
IUC (4% were using an intrauterine device [IUD] and 5% using an intrauterine system 
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[IUS]).2 Accurate data on IUC provided by general practice 
(GP) in the UK are hard to obtain and no national survey 
of contraceptive use has been carried out since 2008–2009, 
when 8% of 15- to 49-year-old reported using an IUC.3 LARC 
prescription rate to women aged 15–44 years in GP (exclud-
ing the contraceptive injection but including contraceptive 
implants and IUC) was 50/1,000 women/year in 2014.4
To explore possible reasons for the low use of IUC in a 
GP setting, we examined the views on IUC of women aged 
18–49 years, attending GP practices in a region of England.
Methods
Ethical approval for this project was obtained from NRES 
Committee London South East (14/LO/0004).
We used a mixed method Qual/Quant approach in which 
the initial qualitative research provides a structure for subse-
quent larger quantitative surveys. Sequential mixed methods 
are increasingly used in health care settings, where qualitative 
findings are drawn on to devise quantitative surveys, whose 
data can help to indicate how prevalent the qualitative find-
ings are in a wider population (Qual/Quant).5
Study design and development of survey 
instrument
Patients were invited to take part in the study through their GP 
practices. First, 30 women from 7 practices gave  written, or 
audio-recorded, informed consent to take part in the qualitative 
interviews. Interviews explored knowledge about, and attitudes 
toward, IUC, including whether it had been considered as a 
method. Only never users of IUC were recruited in this arm. 
The qualitative data were analyzed thematically.6 First, the 
transcripts were read and reread by two independent research-
ers to ensure familiarity with the data. A coding frame was 
then devised and refined through discussion. The transcripts 
were broad coded into themes. Each emerging theme was then 
fine coded. To ensure rigor, the researchers compared their 
interpretation of the data at a number of stages throughout the 
process to ensure that findings were firmly grounded in what 
the research participants themselves had to say.
To help facilitate analysis, the researchers utilized the data 
management software package NVivo (QSR International Pty 
Ltd, Doncaster, Australia). The broad themes arising from the 
qualitative analysis, which informed the quantitative survey, 
were lack of knowledge about IUC, accounts of friends and 
family, concerns about fitting and removal, concerns about 
the hormonal component of levonorgestrel-releasing IUS 
(LNG-IUS), concerns about effects of IUC on the menstrual 
cycle, concerns about the devices moving, falling out or being 
felt during sex, the need to arrange for a clinician to stop or 
start the methods, having a device inside the body, concerns 
about the long-term nature of IUC, and concerns about the 
effects of IUC on the body and fertility.
A quantitative survey, incorporating these themes, was 
subsequently distributed to women (users and non-users) 
within participating GPs (Supplementary material). The sur-
vey asked for demographic data, opinions, experiences and 
knowledge of IUC, current contraceptive method and level of 
agreement, using a discrete visual analog scale (VAS), with 
statements of concern about IUC, which were derived from 
the qualitative interviews. There was also a free-text box in 
which respondents were asked to state their main reason (if 
any) for not using IUC. The survey was piloted before use 
with two separate groups of students (undergraduate and 
postgraduate) in a higher educational establishment, and 
wording of the items was altered according to their feedback 
on acceptability and clarity. The survey was administered in 
English and took about 10–15 minutes to complete.
Survey sample
All women between the ages of 18 and 49 years, attending 
32 selected GP premises between February and August 2015, 
were eligible to take part in the subsequent quantitative sur-
vey, regardless of their reason for attending or contraceptive 
history. A sample size calculation showed that a minimum 
of 1,068 respondents was required to be able to estimate, 
with a 95% confidence interval (CI) half-length of 3%, the 
percentages of attributes or responses in the target popula-
tion, when the true percentage was 50%, the case with the 
largest variance.
Of 4,300 questionnaires distributed, 1,244 questionnaires 
were returned, indicating a response rate of 28.9%. Removing 
blank questionnaires and respondents who were outside the 
intended age range (18–49 years) resulted in 1,195 responses 
for analysis, which exceeded our intended target.
Statistical analysis
Quantitative analysis was carried out using both SPSS and 
“R” software.7 We used descriptive statistics to summarize 
the knowledge of IUC and demographic characteristics and 
Student’s t-tests or Fisher’s exact test to compare these charac-
teristics between users and non-users of IUC. Binary logistic 
regression models were fitted to relate current non-use of IUC 
to each variable in a set of 26 variables in single-predictor 
models and binary logistic regression performed using Firth’s 
penalized maximum likelihood estimation provided by func-
tion logistf from R package logistf.8
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Taking use/non-use of IUC (both copper IUD and IUS) 
as a binary response variable in single-predictor binary logis-
tic models, we looked at which attitudinal or demographic 
variables appeared to predict non-use. The responses to the 
attitudinal statements were recoded so that a response sug-
gesting a greater likelihood of non-use scored more highly. 
For example, “It puts me off a lot” was coded to score highest, 
whereas “It attracts me a lot” was coded to score lowest. The 
results are presented as odds ratios (ORs), which represent a 
greater or lesser likelihood of non-use with every increment 
along the discrete VAS.
Missing responses and “do not know” responses have 
been omitted from the analysis that is presented in Table 1.
Results
Sample characteristics
The mean age of the 1,195 respondents was 33.9 years; 79.8% 
self-identified as White British. The majority of respondents 
were parous (58.5%) and had never experienced an unwanted 
pregnancy (75.6%).
Use of IUC in a UK GP setting
Of our sample, 26.1% reported ever having used IUC: 17.1% 
had used LNG-IUS, 5.7% had used a copper IUD, and 1.6% 
had used both.
When asked about current use, 10.5% reported using a 
LNG-IUS and 2.6% a copper IUD. The most common current 
contraceptive method was the combined oral contraceptive 
pill (Figure 1).
Knowledge of IUC
A total of 45.3% reported knowing “a lot” (10.3%) or “some” 
(35%) about IUC, whereas 25.3% knew “a little” and 26.6% 
“almost nothing”.
Demographic variables vs user/non-user
Nulliparity was statistically significantly associated with 
being a non-user, and parous women reported being cur-
rent IUC users in greater numbers than nulliparous women 
(p<0.001). Of the current users, 82.7% reported having 
had a baby compared to 56.3% of non-users. In a largely 
White British sample, neither ethnicity (p=0.897) nor a 
history of unplanned pregnancy (p=0.134) was statistically 
significantly associated with being a current non-user. The 
mean age of users (38.3 years) was statistically signifi-
cantly higher than the mean age of non-users (33.1 years) 
(t=7.487, p<0.001). For age at recruitment to the survey 
(years), the odds in favor of non-use is reduced by 6.8% 
as age increases by 1 year (OR=0.932 [CI=0.912, 0.951], 
p<0.001).
Predictors of non-use of IUC
Attitudinal variables increasing the odds of being a non-user 
by >2 for each increment along a discrete VAS were
•	 An adverse opinion on long-acting aspect of IUC 
(OR=8.34);
•	 Disliking the thought of IUC inside the body (OR=3.138);
•	 Concerns about IUC causing difficulties becoming preg-
nant in the future (OR=2.587);
•	 Concerns about womb damage (OR=2.224);
•	 Having heard adverse opinions about LNG-IUS 
(OR=2.551);
•	 Adverse opinion on having light, irregular periods 
(OR=2.382);
•	 Adverse opinion on having no periods (OR=2.018).
Concerns about unpleasant fitting and removal, although 
common, were not the strongest predictors of use or non-use 
in this sample.
Table 1 Predictors of non-use of IUC in single-predictor binary 
logistic models
Predictor OR (95% confidence 
limits)
p-Value
Opinion on long-acting feature 8.340 (5.753, 12.489) <0.001
Opinions heard about copper coil 1.820 (1.465, 2.287) <0.001
Opinions heard about IUS 2.551 (2.009, 3.298) <0.001
Appointments off-putting 1.470 (1.241, 1.754) <0.001
Fitting painful 1.529 (1.288, 1.816) <0.001
Fitting embarrassing 1.333 (1.139, 1.569) <0.001
Do not like to ask for removal 1.507 (1.275, 1.794) <0.001
Worry about unpleasant removal 
score
1.504 (1.295, 1.748) <0.001
Worry about womb damage 2.224 (1.863, 2.681) <0.001
Worry about future pregnancy 2.587 (2.122, 3.190) <0.001
Worry about movement inside 1.903 (1.621, 2.246) <0.001
Worry about partner feeling 1.687 (1.435, 1.995) <0.001
Worry about it falling out 1.807 (1.511, 2.180) <0.001
Do not like the thought of it 3.138 (2.617, 3.818) <0.001
Worry about damage to baby 1.512 (1.288, 1.783) <0.001
Attitude to IUS hormones 1.702 (1.434, 2.028) <0.001
Attitude to light/irregular periods 2.382 (2.006, 2.848) <0.001
Attitude to no periods 2.018 (1.720, 2.391) <0.001
Ever had a baby No 1.000
Yes 0.276 (0.177, 0.416) <0.001
Ever had an unwanted pregnancy No 1.000
Yes 0.729 (0.496, 1.091) 0.122
Age at recruitment (years) 0.932 (0.912, 0.951) <0.001
Age at recruitment (decades) 0.494 (0.400, 0.605) <0.001
Abbreviations: IUC, intrauterine contraception; OR, odds ratio; IUS, intrauterine 
system.
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The long-acting nature of IUC
The extent to which a respondent was attracted or “put off ” 
by the long-acting nature of IUC was a strong predictor of 
non-use. The opinion that the long-acting nature of IUC was a 
“good” or “very good” feature of the method was statistically 
significantly associated with current use. For every increment 
along a discrete VAS indicating that the long-acting nature 
of IUC was a negative feature, a respondent was 8 times the 
odds of being a non-user (OR=8.340 [CI=5.753, 12.489], 
p<0.001).
Disliking the thought of IUC inside the body
Disliking the thought of IUC inside the body was also a strong 
predictor of non-use.
For every increment along a 5-point discrete VAS toward 
agreement with this statement “I do not like the thought of 
having something like that inside me”, the odds of a respon-
dent being a non-user increase by 3.1 times (OR=3.138 
[CI=2.617, 3.818], p<0.001).
Concerns about the effect of IUC on future 
pregnancy and the womb
Worries about the effect of using IUC upon future fertil-
ity or upon the womb of the user also predicted non-use. 
For every increment along a 5-point discrete VAS toward 
agreeing with the statement “I worry that it will damage 
my womb”, a respondent had 2.2 times the odds of being a 
non-user (OR=2.224 [CI=1.863, 2.681], p<0.001). Similarly 
for every increment along a 5-point discrete VAS agreeing 
with the statement “I worry that it will make it harder to get 
pregnant in the future”, a respondent had 2.6 times the odds 
of being a non-user (OR=2.587 [CI=2.122, 3.190], p<0.001).
Reported experiences of other people who had 
used IUC
The effect of other people’s experiences of IUC was statisti-
cally significant both for IUD (OR=1.820 [CI=1.465, 2.287], 
p<0.001) and for LNG-IUS (OR=2.551 [CI=2.009, 3.298], 
p<0.001), although it was stronger for LNG-IUS. For every 
shift along a discrete VAS toward knowledge of other people’s 
increasingly bad experience of LNG-IUS, a respondent was 
2.55 times more likely to be a non-user of IUC.
With regard specifically to LNG-IUS, the effect on the 
menstrual cycle was a predictor of non-use. For every incre-
ment along a 5-point discrete VAS toward being “put off 
a lot” by the fact that LNG-IUS can cause light, irregular 
periods, the odds of a respondent being a non-user increased 
by 2.4 times (OR=2.382 [CI=2.006, 2.848], p<0.001).
For every increment along a 5-point discrete VAS toward 
being “put off a lot” by the fact that LNG-IUS can cause 
Figure 1 Current contraceptive use.
Abbreviations: COCP, combined oral contraceptive pill; LNG-IUS, levonorgestrel-releasing intrauterine system; POP, progestogen-only pill; IUD, intrauterine device.
0.0%
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10.0%
15.0%
20.0%
25.0%
Current contraceptive method
Current method (N=1,195)
21.8%
10.5% 10.5%
6.6%
4.3%
2.6% 2.5%
20.5%
3.7% 3.1%
1.8%
12.2%
Pill, COCP, combined pill
LNG-IUS coil
Condoms
POP
Implant
Copper IUD coil
Injection
None
Other response
Vasectomy
Missed question
Pregnant, trying, just had
baby
 
O
pe
n 
Ac
ce
ss
 J
ou
rn
al
 o
f C
on
tra
ce
pt
io
n 
do
wn
lo
ad
ed
 fr
om
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
12
8.
41
.3
5.
98
 o
n 
29
-N
ov
-2
01
6
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Open Access Journal of Contraception 2016:7 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
159
Predictors of non-use of intrauterine contraception
periods to stop completely, the odds of a respondent being a 
non-user increased by 2 times (OR=2.018 [CI=1.720, 2.391], 
p<0.001).
Discussion
The percentages for current use of IUC (13.1%) in this sample 
are somewhat higher than those reported from contraceptive 
clinics in the same time period in the UK. This may reflect 
recruitment bias or may show a different pattern of IUC 
use, and in particular, greater use of LNG-IUS, in GP than 
is recorded in data from contraceptive clinics.
More than half (51.9%) of survey respondents reported 
little or no knowledge of IUC. Previous studies have also 
found that women reported having little reliable information 
on IUC.9–17 Greater IUC knowledge has been associated with 
greater LARC use and positive attitudes toward IUC.17,18
The strongest predictor of non-use was not liking the 
fact that IUC is long acting. Our qualitative interviews, and 
free-text responses in the survey, suggest that concern about 
the health implications of a long-term device in the body 
and plans to conceive within the 5- to 10-year lifetime of the 
methods lie behind the dislike of the long-acting nature of the 
method. The qualitative interview data do not suggest that 
fear of being denied removal of the method (i.e. coercion to 
continue) lies behind this finding, although lack of control 
over stopping the method was cited in some of the free-text 
survey responses. We tentatively suggest that this concern 
may help explain some of the responses in the wider survey 
sample and that this would be an area for further research. 
Better information on the ease of removal and the fact that the 
device can be removed on request may mitigate against this 
concern. Recent work on the acceptability of self-removal of 
IUC is relevant, and this possibility may remove a potential 
barrier to the use of IUC.19,20
Our data indicate that fears about internal damage or 
dislike of the idea of an internal device are strong predictors 
of non-use of IUC. These concerns echo those reported in 
other studies in the UK, Canada, and USA.9–13,16,17,21 These 
are attitudes that could be addressed by clearer information 
about the risks associated with IUC. Negative experiences 
of other people who used the method also predict non-use. 
The “folk memory” of risks with earlier versions of IUC and 
the influence of lay knowledge upon contraceptive decision 
making are consistent with other studies and may not be given 
sufficient weight by clinicians.16,22
The disruptive effect on menstruation of hormonal IUC 
appears to present a barrier to non-use in this sample. We do 
not know how many of this sample of women experienced 
heavy or troublesome periods, and it is possible that this 
feature of the method may be welcomed by women who do 
experience heavier periods.
The belief that irregular or absent periods are unhealthy 
has been previously reported and may be addressed by better 
counseling and information about IUC.13
Our UK-based survey of women’s attitudes to IUC reflects 
many of the findings of surveys carried out in the US and 
Canada. The strong negative effect of the long-acting nature 
of IUC is unexpected and is a new finding.
Limitations and strengths
The recruitment of only non-users to the qualitative interview 
stage of the project means that the concerns enumerated in 
the quantitative survey are not based on first-hand experience 
of using IUC, which is a limitation of our findings.
The sample used in the quantitative arm of this study 
was not randomly generated, limiting the level of scientific 
evidence of the findings. However, the large sample of women 
attending GP for a variety of reasons can be considered a 
“typical” sample and likely to be representative of the range 
of views of women in this context. Those with poor literacy 
skills and those who did not speak English are less likely to 
have completed this survey.
The relatively poor response rate (28.9%) to the survey 
presents a possible source of bias because we have no infor-
mation about the characteristics of non-respondents.
The majority of our sample (79.8%) self-identified as 
White British. Since ethnic differences have been correlated 
with contraceptive preference in the US, it would have been 
useful to have been able to examine whether this effect was 
present in our UK sample.23 However, the small, and ethni-
cally diverse, numbers of non-White British respondents in 
our sample prevented this.
Cross-sectional data such as ours can highlight associa-
tions but cannot prove causality.
Response bias is possible due to the location of recruit-
ment, although this is likely to be reduced because the sur-
veys were completed and returned independently of health 
professionals.
Conclusion
The long-acting nature of IUC is the strongest predictor of 
non-use in this sample. Dislike of the “idea” of the device 
inside the body was also a strong predictor of non-use. The 
negative effect of fears for future pregnancy or about damage 
to the womb suggests that lack of knowledge about IUC, and 
in particular, about the safety profile, acts as a barrier to its 
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uptake. With regard to hormonal IUS, dislike of the effects on 
bleeding patterns predicted non-use. Vernacular knowledge of 
IUC including “folk memories” and other peoples’ accounts 
of bad experiences are strong predictors of non-use.
Implications
There is a requirement for better information for women 
about IUC, which specifically addresses their concerns about 
risks, bleeding patterns, and effects on future fertility, which 
may have been acquired from vernacular accounts. For those 
women who dislike the long-acting nature of IUC, reassur-
ance about removal on request at any time after insertion may 
make IUC more acceptable.
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